Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
| Autor: | Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF, ONTARGET and TRANSCEND Investigators |
|---|---|
| Zdroj: | Circulation; 3/15/2011, Vol. 123 Issue 10, p1098-1107, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|